These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8066678)

  • 1. Lipid and lipoprotein(a) in renal transplant recipients.
    Sugahara S; Koyama I; Yoshikawa Y; Dohi Y; Omoto R
    Transplant Proc; 1994 Aug; 26(4):2080-1. PubMed ID: 8066678
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a) concentrations in chronic renal failure and following renal transplantation.
    Yang CW; Kim YS; Kim SY; Choi EJ; Chang YS; Yoon YS; Bang BK; Koh YB
    Transplant Proc; 1994 Aug; 26(4):2082-3. PubMed ID: 8066679
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
    Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring of lipid anomalies in renal transplantation].
    Mourad G; Vela C; Cristol JP
    Nephrologie; 2000; 21(7):365-6. PubMed ID: 11200613
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.
    Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
    Transplant Proc; 1992 Feb; 24(1):366. PubMed ID: 1539319
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
    Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
    Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lipoprotein A in renal transplant recipients.
    Innocenti M; Lorenzetti M; Naldi F; Paleologo G; Pasquariello A; Marchetti P; Giannarelli R; Rindi P; Navalesi R; Rizzo G
    Transplant Proc; 1998 Aug; 30(5):2048. PubMed ID: 9723386
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.
    Lye WC; Hughes K; Leong SO; Tan CC; Lee EJ
    Transplant Proc; 1995 Feb; 27(1):977-8. PubMed ID: 7879252
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid peroxidation in renal allograft recipients.
    Juskowa J; Paczek L; Barańska E; Rancewicz Z; Stryjecka-Rowińska D; Gradowska L; Wyzgał J; Senatorski G; Cieplak M
    Transplant Proc; 1996 Dec; 28(6):3474-6. PubMed ID: 8962351
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-lipid and lipoprotein patterns of Beijing populations from birth to senescence.
    Li JZ; Li PY; Niu QT; Wang S; Jiang L; Zhao SH; Guo HB; Gao H; Zhang ZM; Fang XZ
    Chin Med J (Engl); 1988 Sep; 101(9):659-64. PubMed ID: 3148409
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.